Intravenous Iron Injection in Cancer Patients With Anemia
Status:
Recruiting
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
- Multifactorial pathogenesis is involved in anemia of cancer patients and defining the
causes of anemia is not always simple.
- Currently, treatment options available for anemia in cancer patients include red blood
cell (RBC) transfusion, erythropoietin stimulating agent (ESA), and iron
supplementation, accompanying considerable pros and cons for each treatment.
- Previous studies have demonstrated benefit when treating with IV iron in combination
with ESA and, more recently, evidence is emerging to suggest a role for IV iron alone.
- In this study, investigator will assess the efficacy of intravenous iron for the
treatment of anemia in cancer patients.
- Improvement of anemia and the improvement of quality of life compared to conservative
treatment of intravenous iron